Information:
Fel:
ID
34330
Beskrivning
Observational,Prospective Study to Develop and Validate a Prognostic Tool to Optimize Therapy in Patients With HCV G1/4; ODM derived from: https://clinicaltrials.gov/show/NCT01884402
Länk
https://clinicaltrials.gov/show/NCT01884402
Nyckelord
Versioner (1)
- 2019-01-16 2019-01-16 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
16 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Hepatitis C, Chronic NCT01884402
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C, Chronic NCT01884402
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
patients with > 18 years old.
boolean
ID.2
Item
patients diagnosed with chronic hepatitis c in the presence of hcv rna in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
boolean
ID.3
Item
patients genotype 1 and 4.
boolean
ID.4
Item
patients with the results of all the factors evaluable at the time of inclusion.
boolean
ID.5
Item
patients who have accepted their participation in the study through informed consent.
boolean
ID.6
Item
patients previously treated with interferon (ifn) and ribavirin (rbv).
boolean
ID.7
Item
patients with genotype 2, 3, 5 and 6.
boolean
ID.8
Item
patients with co-infection with hepatitis b.
boolean
ID.9
Item
patients with other liver diseases.
boolean
ID.10
Item
patients with any contraindications to the drugs used in the treatment of hepatitis
boolean